TheDinarian
Gaming • News • Investing & Finance
⚕️ Ahimsa - First, do no harm. Two new ones for your anticancer toolkit.⚕️
June 29, 2024
post photo preview

ld be best to add Ivermectin to be used along side of theces between my approach and that of the medical industry. First my focus is health, not the disease. My focus is body support, not degradation.

Secol, the medical industry is focused on disease AND they are projecting the “external savior myth” down to the material plane in the form of their reliance on their chemicals to ‘fight the disease’. My approach has been to provide the body with the tools it needs to correct the situation, as well as, the provision of such extra support as may be taken on board with the constant mental attitude of ahimsa, first do no harm.

There are two substances detailed below. These are very impressive, though may be expensive and difficult to obtain. That is a necessary artifact of my working in this area for so many years; that is, the easy fruits have already been picked. However, as the search narrows down, there are surprisingly powerful discoveries yet to be made as evidenced by the two listed below. These descriptions have been created by AI due to my lazy ass approach to things. AI had nothing to do with the finding of these and is a simple tool to aggregate the information that you need to read.

Honokiol, and Fucoidans.

****

Honokiol is a compound found in several plants, particularly in the bark and leaves of the Magnolia tree. It has gained attention for its potential health benefits, including anticancer effects. Here are some of its known health effects:

  1. Anticancer Properties: Honokiol has been studied for its ability to inhibit the growth of various types of cancer cells. It works through several mechanisms, including inducing apoptosis (programmed cell death), inhibiting angiogenesis (the formation of new blood vessels that tumors need to grow), and suppressing metastasis (the spread of cancer cells).

  2. Anti-inflammatory Effects: Honokiol has shown anti-inflammatory properties by inhibiting certain inflammatory pathways in the body. This could potentially benefit conditions where inflammation plays a role, such as arthritis and certain cardiovascular diseases.

  3. Antioxidant Activity: It acts as an antioxidant, scavenging free radicals that can damage cells and contribute to various diseases, including cancer and cardiovascular diseases.

  4. Neuroprotective Effects: Honokiol has been studied for its potential to protect nerve cells from damage and promote their survival. This could have implications for neurodegenerative diseases like Alzheimer's and Parkinson's.

  5. Anxiolytic and Sedative Properties: It has been investigated for its calming effects, which may help reduce anxiety and promote relaxation without causing significant sedation.

  6. Cardiovascular Benefits: Honokiol may have protective effects on the cardiovascular system, including lowering blood pressure and reducing the risk of heart disease.

  7. Antimicrobial Activity: It exhibits antimicrobial properties against certain bacteria and fungi, suggesting potential applications in treating infections.

Fucoidans are a class of complex polysaccharides found primarily in various species of brown seaweed. They have been studied extensively for their potential health benefits, and here are some of their known effects:

  1. Anticancer Properties: Fucoidans have shown promising anticancer effects in various studies. They can inhibit cancer cell proliferation, induce apoptosis (cell death) in cancer cells, and inhibit angiogenesis (the formation of new blood vessels that tumors need for growth). Fucoidans may also suppress metastasis, making them potential candidates for cancer therapy and prevention.

  2. Immunomodulatory Effects: They can modulate the immune system by enhancing the activity of certain immune cells (such as natural killer cells and macrophages) and improving immune response against infections and tumors.

  3. Antioxidant Activity: Fucoidans exhibit antioxidant properties, helping to neutralize free radicals and reduce oxidative stress, which is linked to aging and various chronic diseases.

  4. Anti-inflammatory Effects: They have been shown to reduce inflammation by inhibiting pro-inflammatory cytokines and enzymes, which may benefit conditions like arthritis, inflammatory bowel disease, and cardiovascular diseases.

  5. Antiviral and Antimicrobial Activity: Fucoidans have demonstrated activity against certain viruses and bacteria, suggesting potential applications in antiviral and antimicrobial therapies.

  6. Gastrointestinal Health: They can promote gut health by supporting the growth of beneficial gut bacteria and protecting the intestinal lining, which may help in managing digestive disorders.

  7. Skin Health: Fucoidans have been studied for their potential benefits in skin health, including promoting wound healing, moisturizing the skin, and protecting against UV-induced damage.

  8. Cardiovascular Benefits: They may have protective effects on the cardiovascular system by reducing cholesterol levels, improving blood flow, and supporting heart health.

Both of these substances WILL aid anyone with cancer. These are very powerful in their support for the body and may help those people struggling with the results of the covid vaxx shot.

Best to you. Cancer can be defeated. Universe places all the tools we need before us.

https://clifhigh.substack.com/p/cancer

Link

community logo
Join the TheDinarian Community
To read more articles like this, sign up and join my community today
0
What else you may like…
Videos
Posts
Articles
👀 An Enemy Of Israel 👀

Are you still brainwashed? 🧠
Do you still believe Israel is the Victim? ✡️
Think again... 🤔

👉 This is the full interview of former Congressman James Traficant, who believed his life was in danger for speaking out against AIPAC.

👉 James Traficant tells the story of how he was thrown in jail for several years after taking on the Israeli lobby.

👉 This interview is from April 2014.

👉 He would die five months later in September 2014.

The interview was conducted by @Lukewearechange

00:13:04
⚠️ The Truth Shall Set You Free... ⚠️

Sound Familiar?

"You just have to Flood a country’s public square with raw sewage … eroding the truth… So the citizens don't know what to believe and the game is won." ~ex Unlawful President Obama

00:00:39
😒 Joe Bloopers From Last Nights CNN Debate 😒

Some Bloopers from last nights CNN Debate in Georgia last night.
What a joke!

00:01:34
🪂 Venom Quests Season 2 🪂

💎@Venom_network_ Quests Season 2
💎Complete tasks Earn XP
💎Hold Venom Early Participant NFT Multiplier
💎Enter the Leaderboard
💎Claim Airdrop/Rewards

👇 Participate and Start Earning Today 👇
https://venom.network/referral/C8LEg2UBs6A6Fep1xYCNhW

post photo preview
Large sun-like UFOs spotted in Canada: ‘We’re seeing aliens’

⚠️ Looks like Clif Highs algorithmic readings are once again on mark. -The Dinarian ⚠️

UFOs in Canada: Couple captures multiple orange lights over Winnipeg river
“Yo, I think we’re seeing some aliens! For real!” In Fort Alexander, Canada, Justin Stevenson and his wife, Danielle, were amazed to see several orange lights floating over the Winnipeg River.

“Two bright lights way above the trees,” he described in the now-viral video, before another pair of fiery orbs appeared. “Look, there’s another one! What the f—k is that?”

The couple tried to zoom into the lights and walked towards it to get a better view.

https://x.com/WorldNews_X_/status/1795221250932949029

While some people on social media guessed the UFOs were helicopters or flares from an airplane, Stevenson believes they might be extraterrestrial.

“It was pretty surreal and it felt like we were in a sci-fi movie,” Stevenson said about the May 14 sighting.

“I was skeptical before I saw this, but now this has given ...

post photo preview
👀 The SEC Sues Consensus Accusing Metamask Of Trading Securities 👀
post photo preview
Sony gets ready to launch crypto exchange in Japan with acquired Amber platform

QUICK TAKE

  • A Sony Group subsidiary is rebranding local cryptocurrency exchange Amber Japan, which it acquired last August.
  • Sony’s other Web3 ventures include building its own public blockchain network.

Japan’s multi-industry conglomerate Sony is getting ready to launch a cryptocurrency exchange subsidiary by revamping local trading platform WhaleFin which it acquired last year, according to a Monday press release on PR Times.

WhaleFin has been renamed to S.BLOX Co., which plans to collaborate with Sony Group’s other businesses to generate additional value for its crypto trading services, according to the statement

The revamp also includes a redesign of the user interface and a new mobile app that will be easier to use, the release said. The exact launch date of S.BLOX crypto exchange has not been announced.

The crypto trading entity was initially the Japanese crypto exchange DeCurret, which was first acquired by the Japanese subsidiary of Singapore’s Amber Group in 2022. In August 2023, Sony’s wholly-owned subsidiary Quetta Web Co. acquired the platform, according to a press release from 2022.

Sony has been making efforts to expand its presence in Web3. Sony Network Communications, the conglomerate’s business division, partnered with Japanese blockchain firm Startale Labs last year to build Sony’s own public blockchain network.

Sota Watanabe, founder and CEO of Startale Labs, revealed on X on Monday that Startale’s external director is going to lead Sony’s new crypto exchange, though he did not provide further details.

The PlayStation maker also filed a patent last year for more flexible use of NFTs as in-game assets that it dubbed “super-fungible tokens.”

The Block reached out to Sony and Amber Group for further comment.

Link

Read full Article
post photo preview
EBAday 2024: The time is now for banks to seize the lead in digital money

​How can Europe’s commercial banks and payment firms harness the power of CBDCs, tokenised commercial bank money and programmable payments? The Quant team was at the Euro Banking Association’s annual summit for leading payments and transaction banking executives last month with answers.

Members of the Euro Banking Association gathered last month in Lisbon for their annual conference. Several members of the Quant team attended – as exhibitors and speakers – to contribute to the dialogue.

Over the course of the two-day event, the Quant team met delegates at our stand to share more about our work on the Regulated Liability Network, the UK’s retail central bank digital currency, how Europe’s commercial banks and payment firms could leverage our technology to issue their own digital currencies and the power of programmability in payments.

Alongside our presence at the event, our Founder and CEO, Gilbert Verdian, joined a panel of experts in a session on day one: ‘The challenges and benefits of CBDCs, tokenised deposits and stablecoin adoption’, to discuss the benefits and risks of programmability and how likely the risk of market fragmentation is if banks were to chase after the same use cases.

Moderated by Andrea Meier, Chair of the EBA Working Group on Digital Currencies and Smart Payments, the other panelists were David Cunningham, Head of Strategy & Partnerships for Digital Assets, Treasury and Trade Solutions, Citi; Manuel Klein, Market Management Payments and Digital Currencies, Cash Management, Deutsche Bank; Alessandro Roveda, Head of Network Services Solutions, Nexi Group; and Phoebe Zhou, Head of Emerging Payments – GPS Europe, HSBC.

Meier set the scene by defining the different types of money – both public and private, to which Cunningham added: “We need to get CBDCs right. What will be the effect on commercial banks? We’re developing our own internal capability to tokenise currency and move it.”

Similarly, Klein shared that Deutsche Bank have “partnered with clients and other banks to see how we can issue our own money and implement that. We’ve also analysed how to use blockchain technology to allow 24/7 payments and programmability.”

The conversation then shifted to the benefits of tokenised deposits. Roveda began by pointing out that the industry is already digitalising with DLT but requires a new means of payment flow – this is tokenised deposits.

Gilbert began by describing Quant’s work in this space, building financial infrastructure that makes digital assets and tokenised money interoperable and transforming from electronic payments to digital.

“As a society we operate digitally, but the systems we use were designed as electronic which means our current system is not fit for purpose,” Gilbert said.

 

“Our work with the Bank of England on Project Rosalind and more recently with the Regulated Liability Network has shown us what’s different about these new forms of money, and it comes down to programmability. By embedding logic into money, banks can automate processes, make money intelligent and create space for new types of use cases.”

Klein remarked that by having only commercial banks on a network, the missing piece is settlement. He used Project Agora as an example of a project that hopes to overcome this challenge by having commercial bank money and a settlement asset on the same network. He compared this concept to the RLN.

“We’ve had enough experiments now; we need to be issuing real value and exchanging it,” commented Cunningham. “The key tenet is interoperability – I’m sure Gilbert has some ideas on how this can be achieved.”

​Gilbert agreed with Cunningham’s call for action. “Now is the time for commercial banks to seize the lead in digital money,” he pointed out. “We need to avoid further fragmentation because this will complicate payments.” He added that the other driver is CBDCs – they are coming, and banks need to be ready. The best way for banks to prepare for this is to innovate now, and work with commercial banks to build the necessary infrastructure.

But how can we move from experimentation to production? Zhou shared that banks need to figure out how their back-end systems can integrate with DLT, and then look at building the internal business case.

Closing the session, Gilbert had a clear message for European commercial banks: “Time is running out, there is a risk that banks may lose customers to new entrants if they don’t innovate now. CBDCs are coming, it is better to start today rather than waiting for a mandate to come.”

Link

 

Read full Article
post photo preview
Crypto ETF filings are only ramping up

Exchange-traded frenzy

The SEC’s January approval of spot bitcoin ETFs was a big hurdle cleared, as US crypto fund plans have only ramped up from there. 

You probably know about the imminent launches of US spot ETH funds. A source told Blockworks that issuers could hear from the SEC “at any point” about a listing date for those given the “light” last round of registration amendment revisions.

Industry watchers now wonder whether the agency will let those S-1s go effective prior to July 4, or if it will take a bit more time.

But in some ways that seems like old news, as US spot solana ETF plans have stolen some headlines.

VanEck — a firm already with a spot bitcoin ETF (and a planned ETH product) — led the charge on that front via a Thursday filing in the US. The proposal differs from a planned SOL fund submitted by 3iQ in Canada last week and could be tough to get past regulators at this point.  

Still, 21Shares joined the paperwork party by filing for a US solana ETF of its own on Friday. The company has a Solana Staking ETP trading in Europe with $850 million in assets. 

“While including a crypto token in a CME futures contract has legal precedent, it should not be the sole criterion for ETF eligibility,” 21Shares legal head Andrew Jacobson said in a statement.

It’s probably worth mentioning too that ETF powerhouse State Street Global Advisors said Wednesday it was partnering with Galaxy Digital to launch “the next generation of digital asset-based strategies.”

The firms together filed for three funds, including a Digital Asset Ecosystem ETF that would invest in crypto equities and futures contracts, as well as in ETFs that hold spot crypto or futures. 

SSGA’s entrance is certainly something to watch, particularly if they end up choosing to launch spot crypto products. The company has plenty of brand recognition and its physically backed gold ETF (GLD) is the largest of its kind, with roughly $62 billion in assets. 

Even before the SOL and SSGA fund filings, Hashdex revealed plans (on June 18) for a fund that would hold both BTC and ETH. 

Not to mention the SEC is still considering a planned spot bitcoin ETF that combines BTC exposure with carbon credit futures. Oh, and a separate fund proposed Wednesday would invest in futures and ETFs related to both bitcoin and gold.

Bottom line, the crypto-related ETF stack on the SEC’s desk is sizable — and likely to get bigger

US spot ETH and SOL ETFs may have seemed like an utter fantasy in early 2023. But BlackRock would enter the spot bitcoin fund race mid-year. Grayscale then won a lawsuit, the SEC cleared ether futures ETFs and, last month, approved the 19b-4s for spot ETH ETFs.  

To some, the SEC giving its blessing to a SOL ETF might feel like a pipe dream, and maybe it is (at least in the near-term). But it’s hard to deny we appear to be in a new era of crypto ETF innovation. 

If the SEC filings webpage isn’t among your bookmarked tabs, you might want to add it.

Link

Read full Article
See More
Available on mobile and TV devices
google store google store app store app store
google store google store app tv store app tv store amazon store amazon store roku store roku store
Powered by Locals